Melorheostosis is a rare bone disease that presents as sclerotic lesions growing on existing bone surfaces. This disease is of unknown etiology and affects both genders equally. The disease ...

The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.

Studies suggest that approximately 1,500 to 2,000 new cases of childhood cancer are diagnosed annually in Uganda ...

Early symptoms of neuroblastoma are similar to other common diseases. However, this disease is not a common disease, but a ...

The 'original non-professional star' and 'leading ghost' Jang Bo-kyu (1st generation, B1, Daejeon) has returned to Gwangmyeong Speedome after four years. His name has appeared on the candidate ...

The repetitive loading of cricket fast bowling may cause bone marrow oedema (BMO), detectable on MRI, before the bowler suffers from symptomatic bone stress injury. We investigated the temporal ...

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

Feb. 14, 2025 — Aging is a privilege, but it also brings risks -- including an increased likelihood of developing age-related diseases including ... Routine Brain MRI Screening in Asymptomatic ...

as the firm gears up for clinical trials of its lead drug for rare bone diseases. Based in Boston, Massachusetts, the company plans to raise $75 million by offering 5 million shares at a price ...

Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion−Israel Institute of Technology, Haifa 3525422, Israel Rappaport Technion Integrated Cancer Center, Technion − ...